Diagnosis and Treatment of Patients with Testicular Germ Cell Cancer

This publication has 100 references indexed in Scilit:

• Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy
  European Journal Of Cancer, 1995
• High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours
  European Journal Of Cancer, 1995
• Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1994
• Predictors of residual mass histology following chemotherapy for metastatic non-seminomatous testicular cancer: a quantitative overview of 996 resections
  European Journal Of Cancer, 1994
• The activity of single-agent carboplatin in advanced seminoma
  European Journal Of Cancer, 1992
• Immediate Adjuvant Chemotherapy versus Observation with Treatment at Relapse in Pathological Stage II Testicular Cancer
  New England Journal of Medicine, 1987
• Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide
  New England Journal of Medicine, 1987
• Tumor classification and size in germ-cell testicular cancer. Influence on the occurrence of metastases
  Cancer, 1982
• The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support
  Published by Elsevier ,1981
• Report on the international workshop on staging and treatment of testicular cancer
  Published by Elsevier ,1980